https://it.prisysbiotech.com/ Non - Umano Primate Ricerca Piattaforma & CRO | PRISYS Biotecnologia https://it.prisysbiotech.com/uploads/39406/logo.png https://it.prisysbiotech.com/safety-evaluation/ Valutazione della sicurezza https://it.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://it.prisysbiotech.com/translation-research/ Ricerca sulla traduzione https://it.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://it.prisysbiotech.com/nhp-pharmacology/ Farmacologia NHP https://it.prisysbiotech.com/uploads/39406/list/n20240227154733ebf63.jpg https://it.prisysbiotech.com/biosafety-research/ Ricerca sulla biosicurezza https://it.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://it.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://it.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://it.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://it.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://it.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://it.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://it.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg Toxicokinetics https://it.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg https://it.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://it.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-teste7c22.jpg Dose Range Finding Test https://it.prisysbiotech.com/uploads/39406/page/dose-range-finding-teste7c22.jpg https://it.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://it.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://it.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://it.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://it.prisysbiotech.com/uploads/39406/page/small/what-is-a-nhp-study0fe0f.jpg What Is A NHP Study https://it.prisysbiotech.com/uploads/39406/page/what-is-a-nhp-study0fe0f.jpg https://it.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg https://it.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://it.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://it.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://it.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://it.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://it.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://it.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://it.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://it.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://it.prisysbiotech.com/uploads/202339406/small/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg NHP Asthma/atopic Dermatitis Model https://it.prisysbiotech.com/uploads/202339406/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg https://it.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://it.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://it.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://it.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg AMD Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg https://it.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://it.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://it.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://it.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg Glaucoma Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg https://it.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://it.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://it.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://it.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg Inflammatory Bowel Disease Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg https://it.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://it.prisysbiotech.com/uploads/202339406/small/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg New And Modified Applications https://it.prisysbiotech.com/uploads/202339406/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg https://it.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg Myopia Hyperopia Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg https://it.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg https://it.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://it.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://it.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://it.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://it.prisysbiotech.com/pk-pd-adme/adme.html ADME https://it.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://it.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://it.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://it.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://it.prisysbiotech.com/uploads/202339406/small/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg Translational Studies https://it.prisysbiotech.com/uploads/202339406/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg https://it.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://it.prisysbiotech.com/uploads/39406/page/small/pharmacokineticsa44cd.jpg Pharmacokinetics https://it.prisysbiotech.com/uploads/39406/page/pharmacokineticsa44cd.jpg https://it.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://it.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://it.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://it.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://it.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://it.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://it.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg Neuropathic Pain Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg https://it.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity https://it.prisysbiotech.com/uploads/202339406/small/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg Immunotoxicity https://it.prisysbiotech.com/uploads/202339406/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg https://it.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://it.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://it.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://it.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://it.prisysbiotech.com/uploads/202339406/small/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg NHP Non-Alcoholic Steatohepatitis (NASH) Model https://it.prisysbiotech.com/uploads/202339406/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg https://it.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://it.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://it.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://it.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://it.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://it.prisysbiotech.com/uploads/202339406/small/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://it.prisysbiotech.com/uploads/202339406/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg https://it.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/small/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg Uveitis Nonhuman Primates Disease Model https://it.prisysbiotech.com/uploads/202339406/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg https://it.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://it.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://it.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://it.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://it.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://it.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://it.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://it.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://it.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://it.prisysbiotech.com/translation-research/clinical-imaging.html Imaging clinico https://it.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Imaging clinico https://it.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://it.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://it.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://it.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://it.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://it.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://it.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://it.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://it.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://it.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://it.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://it.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://it.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://it.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://it.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Modello di diabete mellito di tipo 2 https://it.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Modello di diabete mellito di tipo 2 https://it.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://it.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://it.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://it.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://it.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://it.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://it.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://it.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://it.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://it.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://it.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://it.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://it.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://it.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://it.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://it.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://it.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://it.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://it.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://it.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://it.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://it.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://it.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://it.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://it.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://it.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://it.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://it.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://it.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://it.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://it.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://it.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://it.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://it.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://it.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://it.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://it.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://it.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://it.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://it.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://it.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://it.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://it.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://it.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://it.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://it.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://it.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724146833335296.html Riepilogo 2025: come Prisys sta ridefinendo l'affidabilità traslazionale nella ricerca NHP https://it.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://it.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551215561155584.html NHP - Basati sulla farmacologia e sui servizi farmacodinamici|Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://it.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17528815954666496.html Incontra Prisys Biotech al prossimo Roadshow UE: settembre 2025 https://it.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://it.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17440317583582208.html Prisys Biotech-2025 Review a metà anno https://it.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://it.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244685824123904.html Incontra Prisys nel prossimo US-Roadshow nel marzo 2025 https://it.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://it.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84013624.html Rapporto annuale PRISYS 2024: progresso dei modelli NHP e della ricerca preclinica https://it.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://it.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77700583.html Newsletter Prisys Biotech 2° trimestre 2024 - Ricerca e sviluppo preclinici migliorati per le terapie del sistema nervoso centrale con i modelli PRISYS a reattività crociata https://it.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://it.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81121383.html Mirata Terapia Per Parkinson's Malattia: Scoperta in Real-Time MRI-Guided Trapianto di cellule staminale https://it.prisysbiotech.com/uploads/39406/news/n202409061001122b75a.jpg https://it.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724146900509696.html Quando il dolore diventa un ricordo: fattori emotivi del dolore cronico e il vantaggio del modello NHP|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://it.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724146794767360.html Valutazione del dolore multi-endpoint: il futuro dello sviluppo di farmaci analgesici https://it.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://it.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724146861237248.html Perché così tanti analgesici falliscono negli studi preclinici? La risposta sta nel modo in cui misuriamo il dolore https://it.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://it.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724146903311360.html Progettazione del punto temporale del prelievo di sangue negli studi di farmacocinetica (PK)|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://it.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724147581608960.html Statistiche PK: parametri di analisi non-compartimentale (NCA) e applicazioni precliniche https://it.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://it.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724146805810176.html Perché i modelli di primati non- umani sono fondamentali per la terapia con oligonucleotidi del sistema nervoso centrale https://it.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://it.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724146839954432.html Metabolismo dell'acido urico negli esseri umani e nelle scimmie: implicazioni traslazionali per lo sviluppo di farmaci https://it.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://it.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724146853684224.html Modello di fibrosi epatica associata non-primate umano MASH-|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://it.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724146873967616.html Perché l'IMRI-la somministrazione guidata di farmaci al cervello è essenziale per un targeting preciso negli studi NHP https://it.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://it.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674283293860864.html Sistema di analisi comportamentale 3D NHP senza marcatori basato sull'intelligenza artificiale|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://it.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674283366638592.html LPS-Modello NHP di infiammazione polmonare acuta indotta (ALI)|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://it.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674283361903616.html Modello HDM+SEB-di dermatite atopica indotta (AtD) nelle scimmie Cynomolgus https://it.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://it.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674283423474688.html Spiegazione dei modelli PK da uno- a più-compartimenti|Farmacocinetica NHP|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://it.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674283509244928.html Come scegliere una CRO preclinica affidabile|Criteri chiave per le aziende biotecnologiche|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://it.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674283345077248.html Valutazione CAR-T traslazionale: competenza in vitro e supporto allo studio NHP — Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://it.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674283359134720.html Perché più del 90% dei candidati ai farmaci per il sistema nervoso centrale falliscono gli studi clinici? https://it.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://it.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674283323859968.html Modelli preclinici della malattia di Parkinson: una guida per selezionare modelli di neurotossine, genetici e NHP|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://it.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674283377435648.html Piattaforme traslazionali NHP ad alta-precisione e piattaforme traslazionali-guidate dall'intelligenza artificiale https://it.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://it.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625020195857408.html Modelli di immunologia NHP guidati da Th17|Ricerca autoimmune traslazionale presso Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://it.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625020349801472.html Sistema NHP BehaviorAtlas® basato sull'intelligenza artificiale-|Piattaforma di analisi comportamentale 3D|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://it.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625020376753152.html Modello RFP per studi NHP|Accelerare l’efficienza della ricerca preclinica https://it.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://it.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625020190254080.html Modello del dolore dell'allodinia fredda nelle scimmie Cynomolgus|Biotecnologie Prisys https://it.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://it.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625020470961152.html MRI-Piattaforma di somministrazione intracerebrale guidata di farmaci|Prisys Biotech Ricerca sul sistema nervoso centrale https://it.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://it.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625020559647744.html Modelli di malattie respiratorie NHP e piattaforma di somministrazione di farmaci per le vie aeree|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://it.prisysbiotech.com/news/nhp-renal-biopsy-17625097671615488.html Piattaforma per biopsia renale NHP e modelli di malattie renali|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n20251022172158e338d.jpg https://it.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625020469437440.html Studi PK e somministrazione mirata di farmaci|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://it.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625058361713664.html Piattaforma di ricerca NHP e analisi comportamentale basata sull'intelligenza artificiale di Prisys Biotechnologies- https://it.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://it.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625020086166528.html Tecnologia di somministrazione dal naso-al-cervello (N2B) per la ricerca sul sistema nervoso centrale|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://it.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625020066456576.html SHR-2004: Una svolta nella prevenzione del TEV per le pazienti affette da cancro ovarico: una storia di successo di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://it.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537876423779328.html Modelli di scimmia Cynomolgus e Rhesus|Prisys Biotech Preclinical Cro https://it.prisysbiotech.com/uploads/39406/news/n202509191421539fa9b.jpg https://it.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17528815769428992.html Fibrosi polmonare idiopatica (IPF) Modello NHP|Prisys Biotech Preclinical Cro https://it.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://it.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17528815965168640.html Cynomolgus Monkey Biodistribution Studies|Prisys Biotech Preclinical Cro https://it.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://it.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17528816066487296.html Prisys Biotech Modelli NHP per la ricerca ematologica e ictus https://it.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://it.prisysbiotech.com/news/the-importance-of-administration-volume-17528815760040960.html L'importanza del volume dell'amministrazione negli studi preclinici|Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://it.prisysbiotech.com/news/brain-targeted-drug-delivery-17528815854248960.html Brain - consegna di farmaci mirati|Prisys Biotech Preclinical NHP Research https://it.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://it.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17528815968166912.html Sviluppo di farmaci ADC|Framework PK/PD traslazionale in studi NHP preclinici https://it.prisysbiotech.com/uploads/39406/news/n2025081814020269ffa.jpg https://it.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17493756541805568.html Modelli di dolore NHP per la scoperta di farmaci traslazionali|Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://it.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17493756463539200.html Siero vs. Plasma: scelta della matrice ottimale per bioanalisi preclinica https://it.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://it.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17493756498125824.html Linee guida per il dosaggio preclinico: volume IV e PO, pH e osmolarità per PK accurato in NHP e altre specie https://it.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://it.prisysbiotech.com/news/nhp-copd-model-17493757079823360.html Modelli di ricerca della BPCO superiore e eccellenza della piattaforma respiratoria di Prisys https://it.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://it.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17493756476695552.html Modello di emorragia acuta NHP: uno strumento cruciale per accelerare il nuovo sviluppo di farmaci ematologici https://it.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://it.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17493756411716608.html Ricerca Pruritus: modello NHP indotto da IL-31 di Prisys Biotech per la valutazione delle terapie anti-fuoristrada https://it.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://it.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17440279996392448.html A Guide to Anti-Drug Anticorpy (ADA) Assessment https://it.prisysbiotech.com/uploads/39406/news/n2025071015011851653.jpg https://it.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17440250829923328.html Terapie respiratorie: la piattaforma NHP integrata di Prisys Biotech per la ricerca preclinica https://it.prisysbiotech.com/uploads/39406/news/n202507080951326501f.gif https://it.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17440251341448192.html Modelli di dolore NHP: accelerare lo sviluppo di farmaci analgesici presso Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://it.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17440250469704704.html Piattaforme modello NHP per supportare lo sviluppo dei farmaci in malattie complesse https://it.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://it.prisysbiotech.com/news/key-considerations-for-dosing-volume-17440251300160512.html Considerazioni chiave per il volume del dosaggio, il pH e la formulazione nei modelli animali https://it.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://it.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17440251211342848.html Exosomi ingegnerizzati: rivoluzionamento della consegna di farmaci per i disturbi del SNC - Insights precliniche di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20250617131838d8cea.jpg https://it.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17440250655958016.html Principi guida per la selezione delle specie animali negli studi tossicologici del farmaco dell'acido nucleico https://it.prisysbiotech.com/uploads/39406/news/n202506131705069d4cc.jpg https://it.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17440250586555392.html Prisys Biotech Advanced DSA e IMRI per studi ematologici, vascolari e renali https://it.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://it.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17440250452288512.html Cynomolgus Monkey Pain Models: alimentazione di ricerche traslazionali per il canale ionico rivoluzionario Therapeutics https://it.prisysbiotech.com/uploads/39406/news/n20250605125053411da.jpg https://it.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17440250745971712.html Avanzando la ricerca sulla dermatite atopica: il modello di primati non umani (NHP) di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://it.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17440250673816576.html Modello di dermatite atopica NHP di Prisys Biotech per lo sviluppo di farmaci anti-prurizzati https://it.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://it.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17382180921254912.html Progettazione di studi sugli animali: considerazioni chiave per il successo della ricerca preclinica https://it.prisysbiotech.com/uploads/39406/news/n2025052317011698995.jpg https://it.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17382144994419712.html Dermatite atopica: come i modelli di scimmia di Cynomolgus avanzano terapeutica di precisione https://it.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://it.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17382144999744512.html Ricerca sull'asma: perché i modelli di primati non umani sono fondamentali per lo sviluppo di nuovi farmaci https://it.prisysbiotech.com/uploads/39406/news/n20250512174400b2bec.jpg https://it.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17382146684969984.html Comprensione della farmacocinetica dell'oligonucleotide antisenso (ASO): fattori chiave nell'assorbimento e nella distribuzione https://it.prisysbiotech.com/uploads/39406/news/n202505081658273697e.jpg https://it.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17382148543046656.html Studi per inalazione di NHP per i biologici: Servizi CRO preclinici specializzati di Prisys https://it.prisysbiotech.com/uploads/39406/news/n2025043015244899508.jpg https://it.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17382145016652800.html Studi avanzati di inalazione preclinica: capacità tecniche e competenze presso Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n202504291646054725d.jpg https://it.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17382145014260736.html Comprensione della farmacocinetica (PK): parametri chiave e applicazioni nello sviluppo dei farmaci https://it.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://it.prisysbiotech.com/news/intracerebroventricular-icv-injection-17382145136075776.html Iniezione intracerebroventricolare (ICV): consegna del sistema nervoso centrale per la ricerca preclinica https://it.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://it.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17382144939156480.html Iniezione intracerebrale (ICM): targeting di precisione per terapie del SNC - considerazioni precliniche https://it.prisysbiotech.com/uploads/39406/news/n202504180938433bda1.jpg https://it.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17382144942531584.html Iniezione intratecale (IT): un percorso di consegna del SNC diretto per terapie avanzate - Considerazioni precliniche https://it.prisysbiotech.com/uploads/39406/news/n202504160948404ad29.jpg https://it.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17382144960177152.html Avanzando la ricerca sulla malattia di Parkinson con il modello NHP https://it.prisysbiotech.com/uploads/39406/news/n202504111626379b25c.jpg https://it.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17382145051059200.html Studi PK\/PD preclinici e modelli NHP per lo sviluppo dei farmaci|Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n2025040809451573e94.png https://it.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17300150869779456.html Targeting Interleukin -31 (il -31): una nuova frontiera nello sviluppo del farmaco della malattia autoimmune - Modelli NHP Prisys Biotech per la ricerca preclinica https://it.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://it.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295796335371264.html Valutazione dell'immunotossicità non clinica: strategia, considerazioni chiave e selezione del metodo https://img01.v15cdn.com/gallery/4x3/232.webp https://it.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295796085597184.html Test microbici e il suo impatto sui primati non umani negli studi DMPK preclinici https://it.prisysbiotech.com/uploads/39406/news/n20250325170337bc1d3.jpg https://it.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295796192388096.html Modello di endometriosi della scimmia di Cynomolgus per l'avanzare della ricerca terapeutica https://it.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://it.prisysbiotech.com/news/membranous-nephropathy-model-17295796013556736.html Avanzamento della nefropatia membranosa (MN) Sviluppo di farmaci: Prisys Biotech's Cynomolgus Monkey Model Platform https://img01.v15cdn.com/gallery/4x3/148.webp https://it.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295796175643648.html Farmacocinetica di farmaci per inalazione: un passaggio di paradigma dall'esposizione sistemica a polmonare https://it.prisysbiotech.com/uploads/39406/news/n20250310174924e6965.png https://it.prisysbiotech.com/news/animal-models-for-womens-health-17295795981837312.html Prisys Biotech: Modelli animali per la salute delle donne terapeutiche https://it.prisysbiotech.com/uploads/39406/news/n202503071009566b10b.png https://it.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295796455760896.html Giorno dell'obesità mondiale|Prisys Biotech NHP Metabolic Modelli: alimentare lo sviluppo di terapie anti-obesità di prossima generazione https://it.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://it.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295796150313984.html Prisys Biotech's Cynomolgus Monkey Psoriasi Modello: Avanzamento della valutazione della farmacodinamica preclinica https://it.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://it.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295796389078016.html Biopsia epatica: una tecnica cruciale negli studi farmacocinetici di grandi animali (PK) per lo sviluppo di nuovi farmaci https://it.prisysbiotech.com/uploads/39406/news/n2025022509490064708.png https://it.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295796156474368.html Integrazione di farmacocinetica e farmacodinamica nello sviluppo di farmaci https://it.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://it.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295796195337216.html Cosa convalida davvero la prova del concetto (POC) nello sviluppo dei farmaci? https://it.prisysbiotech.com/uploads/39406/news/n20250218092412fb5f5.jpg https://it.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295795954869248.html Modelli animali|Sfide e applicazioni nello sviluppo del modello di dolore https://it.prisysbiotech.com/uploads/39406/news/n202502141328261a025.png https://it.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295796381737984.html Ricerca farmacodinamica non clinica https://it.prisysbiotech.com/uploads/39406/news/n2025021214305230811.jpg https://it.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244686213096448.html Selezione del primati non umani ideali per studi tossicologici: Cynomolgus Macaque, Rhesus Macaque e Marmoset https://it.prisysbiotech.com/uploads/39406/news/n20250205142604591d8.jpg https://it.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295795959227392.html Lupus eritematoso sistemico (SLE) e il ruolo dei modelli animali nello sviluppo terapeutico https://it.prisysbiotech.com/uploads/39406/news/n20250121104603461db.jpg https://it.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295795993601024.html Modello di primati non umano per l'artrite reumatoide (RA) https://it.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://it.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295795955672064.html Strumenti stereotassici del cervello animale basati su sistemi di coordinate 3D https://it.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://it.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295796460971008.html Modelli animali per test in vivo (1): stabilimento e classificazione https://it.prisysbiotech.com/uploads/39406/news/n20250112202508b936b.jpg https://it.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84013550.html Esplorazione delle possibili vie d'ingresso dei farmaci biologici nel cervello https://it.prisysbiotech.com/uploads/39406/news/n202501071034417382f.png https://it.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84013552.html Avanzamento della ricerca sull'artrite reumatoide (RA) con modelli di primati non umani https://it.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://it.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84013551.html Esplorazione di modelli animali per l'efficacia dei farmaci contro la dermatite atopica https://it.prisysbiotech.com/uploads/39406/news/n202412301624286dab0.jpg https://it.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84014157.html Il ruolo critico dei modelli animali nella ricerca sulle malattie umane https://it.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://it.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84013553.html Il modello della scimmia con deficienza del gene Parkin rivela nuovi meccanismi e bersagli terapeutici per la malattia di Parkinson https://it.prisysbiotech.com/uploads/39406/news/n20241224162504c3c54.jpg https://it.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84014159.html Guida allo sviluppo di farmaci non clinici: studi sulla tossicità generale acuta, subacuta, subcronica e cronica https://it.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://it.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84013549.html Somministrazione innovativa di farmaci dal naso al cervello (N2B): bypassare la barriera emato-encefalica https://it.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://it.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84014156.html Opportunità e sfide dei maialini mini come specie animale di grandi dimensioni non clinica https://it.prisysbiotech.com/uploads/39406/news/n2024120911110171c55.jpg https://it.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-82994858.html Strategie di somministrazione di farmaci per le malattie cerebrali https://it.prisysbiotech.com/uploads/39406/news/n202412030944155b417.jpg https://it.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-82995588.html Navigazione MRI intraoperatoria in tempo reale: supporto all'approvazione da parte della FDA della prima terapia genica per il deficit di AADC https://it.prisysbiotech.com/uploads/39406/news/n202411280914044b8c7.jpg https://it.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-82997652.html Studi sulla tossicità oculare dei colliri: esposizione ai farmaci e valutazione della sicurezza https://it.prisysbiotech.com/uploads/39406/news/n20241126163322d869c.jpg https://it.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82655912.html Prisys Biotech crea un modello di psoriasi della scimmia Cynomolgus per accelerare lo sviluppo di farmaci https://it.prisysbiotech.com/uploads/39406/news/n2024111910582749e02.jpg https://it.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82655909.html Modelli completi di primati non umani per la ricerca sulle malattie renali di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n2024111511090891eb1.jpg https://it.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82655906.html Valutazione preclinica completa della sicurezza dei coniugati farmaco-anticorpo (ADC) nei primati non umani https://it.prisysbiotech.com/uploads/39406/news/n20241111141121c84f3.jpg https://it.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82655930.html Valutazione farmacocinetica dei coniugati farmaco-anticorpo (ADC) nei primati non umani https://it.prisysbiotech.com/uploads/39406/news/n202411081401283f377.jpg https://it.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82655902.html Valutazione farmacodinamica degli ADC https://it.prisysbiotech.com/uploads/39406/news/n20241106161502bd911.jpg https://it.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82655903.html Comprensione del DMPK dei farmaci ADC https://it.prisysbiotech.com/uploads/39406/news/n20241029101148c4fbd.jpg https://it.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82655908.html Progressi nello sviluppo di farmaci a base di acido nucleico e capacità di ricerca di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n2024101713330113621.jpg https://it.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395247.html Progressi nei sistemi di rilascio polmonare dell'mRNA e servizi innovativi di Prisys biotech https://it.prisysbiotech.com/uploads/39406/news/n20241014090616a9ff8.jpg https://it.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82655915.html Perché il Premio Nobel 2024 per la fisiologia e la medicina è stato assegnato a questi due scienziati che hanno studiato il microRNA? https://it.prisysbiotech.com/uploads/39406/news/n20241008113621e90e6.jpg https://it.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82655904.html Considerazioni farmacocinetiche (PK) per i farmaci del sistema nervoso centrale (SNC). https://it.prisysbiotech.com/uploads/39406/news/n2024092913295797d3f.jpg https://it.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656483.html Progressi nella ricerca sul sistema nervoso centrale: sistema di iniezione cerebrale compatibile con la risonanza magnetica e tecnologia CED di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n202408062147375802b.jpg https://it.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81121643.html Avanzamento delle innovazioni terapeutiche per sanguinamento e coagulazione con il modello MCAO della scimmia Cynomolgus https://it.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://it.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81121644.html Valutazione DMPK dei farmaci del sistema nervoso centrale (SNC) https://it.prisysbiotech.com/uploads/39406/news/n20240924110059a8fdd.png https://it.prisysbiotech.com/news/animal-models-of-human-diseases-81121373.html Modelli animali di malattie umane https://it.prisysbiotech.com/uploads/39406/news/n20240920153353a85bd.png https://it.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81121371.html Innovazioni nella valutazione del dolore: analisi comportamentale basata sull'intelligenza artificiale https://it.prisysbiotech.com/uploads/39406/news/n2024091816220958caa.png https://it.prisysbiotech.com/news/china-experimental-monkey-industry-81121374.html Storia, stato attuale, sfide e opportunità dell'industria sperimentale cinese delle scimmie https://it.prisysbiotech.com/uploads/39406/news/n20240909130237c0dc8.jpg https://it.prisysbiotech.com/news/human-disease-animal-models-81121372.html Modelli animali di malattie umane: uno strumento cruciale per far progredire la ricerca biomedica https://it.prisysbiotech.com/uploads/39406/news/n20240904101437e1414.jpg https://it.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81121377.html L'importanza della farmacodinamica preclinica nello sviluppo di farmaci|Prisys Biotecnologia https://it.prisysbiotech.com/uploads/39406/news/n202408281439443e4db.jpg https://it.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81121370.html Somministrazione intranasale negli studi sugli animali https://it.prisysbiotech.com/uploads/39406/news/n20240827104336fadf5.png https://it.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410784.html Rivoluzionando lo sviluppo di farmaci per il sistema nervoso centrale: PRISYS Biotech presenta la tecnologia IMRI https://it.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://it.prisysbiotech.com/news/convection-enhanced-delivery-81121376.html Avanzamento della medicina di precisione: tecnologia CED (Convection-Enhanced Delivery) di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20240822125521f1687.jpg https://it.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81121381.html Cynomolgus Scimmia Cronica Rene Malattia (CKD) Modello Di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://it.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79528862.html Valutazione non clinica della sicurezza della somministrazione oculare di farmaci utilizzando macachi Cynomolgus https://it.prisysbiotech.com/uploads/39406/news/n2024080116325669291.png https://it.prisysbiotech.com/news/compartment-pk-model-81121378.html Comprensione dei modelli compartimentali e non compartimentali nella farmacocinetica https://it.prisysbiotech.com/uploads/39406/news/n202408121135341dcc9.jpg https://it.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79528873.html Il ruolo dell'AAV nella terapia genica: risposte immunitarie e tossicità https://it.prisysbiotech.com/uploads/39406/news/n20240801163452493e1.png https://it.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81121369.html Tecniche avanzate di somministrazione del SNC alle scimmie Cynomolgus: accelerazione dello sviluppo di farmaci oligonucleotidici https://it.prisysbiotech.com/uploads/39406/news/n20240809165539b61ef.jpg https://it.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79528864.html Strategie di valutazione dell'immunogenicità non clinica ottimizzate https://it.prisysbiotech.com/uploads/39406/news/n2024080116353273f4d.png https://it.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79528851.html Riduzione dell'uso di primati non umani nelle valutazioni di sicurezza non cliniche: prospettive della FDA e dell'industria https://it.prisysbiotech.com/uploads/39406/news/n20240801163624dabc0.png https://it.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79528880.html Bioanalisi preclinica LCMS dei farmaci per la terapia genica basati su LNP https://it.prisysbiotech.com/uploads/39406/news/n20240801181230b6a27.jpg https://it.prisysbiotech.com/news/mrna-based-therapies-past-79528876.html Terapie basate sull'mRNA: passato https://it.prisysbiotech.com/uploads/39406/news/n2024080118112364d2d.jpg https://it.prisysbiotech.com/news/pk-strategies-of-pdc-79528844.html Strategie di studio farmacocinetico dei coniugati peptide-farmaco (PDC) https://it.prisysbiotech.com/uploads/39406/news/n2024080109123097cb8.png https://it.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79528884.html Valutazione farmacodinamica (PD) della terapia genica https://it.prisysbiotech.com/uploads/39406/news/n20240801180623d1663.jpg https://it.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79528859.html Farmacocinetica e bioanalisi dei farmaci oligonucleotidici-(1) https://it.prisysbiotech.com/uploads/39406/news/n20240801180452c5c2a.jpg https://it.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79528875.html Farmacocinetica e bioanalisi dei farmaci oligonucleotidici: assorbimento e caratteristiche farmacocinetiche plasmatiche (PK) https://it.prisysbiotech.com/uploads/39406/news/n20240801180317bc744.jpg https://it.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79528867.html Fattori da considerare per l'immunogenicità dei farmaci oligonucleotidici https://it.prisysbiotech.com/uploads/39406/news/n202408011801502cfb9.jpg https://it.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79528886.html MRNA: uno strumento potente e versatile per combattere le malattie - Prisys-Biotech https://it.prisysbiotech.com/uploads/39406/news/n202408011756272a013.jpg https://it.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79528855.html Scienziati cinesi propongono nuove strategie per invertire i sintomi principali del morbo di Parkinson https://it.prisysbiotech.com/uploads/39406/news/n20240801175516ecb8a.jpg https://it.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79528874.html Prisys Biotechnology: Nuove nanoparticelle lipidiche per la somministrazione di MRNA nei primati https://it.prisysbiotech.com/uploads/39406/news/n2024080117542971a31.jpg https://it.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79528868.html L’importanza della ricerca in medicina traslazionale dalla ricerca di base agli studi clinici https://it.prisysbiotech.com/uploads/39406/news/n20240801175156b8ed0.jpg https://it.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79528860.html I principali fattori considerati nell'analisi WOE https://it.prisysbiotech.com/uploads/39406/news/n20240801175020842f8.jpg https://it.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79528869.html Come somministrare farmaci biologici al cervello? https://it.prisysbiotech.com/uploads/39406/news/n20240801174910a58bb.jpg https://it.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79528856.html Come i farmaci si muovono e cambiano nel nostro corpo: una breve introduzione alla farmacocinetica https://it.prisysbiotech.com/uploads/39406/news/n202408011748076fca9.jpg https://it.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79528871.html Come sviluppare nuovi farmaci in modo più rapido e sicuro: una guida agli studi preclinici DMPK https://it.prisysbiotech.com/uploads/39406/news/n2024080117445005c7b.jpg https://it.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79528878.html Linee guida per l'alloggio di gruppo per scimmie da laboratorio https://it.prisysbiotech.com/uploads/39406/news/n2024080117440822f67.jpg https://it.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79528850.html Il ruolo fondamentale delle scimmie sperimentali nel progresso della ricerca scientifica https://it.prisysbiotech.com/uploads/39406/news/n20240801174211d2a1b.jpg https://it.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79528872.html Comprensione di Macaca Fascicularis (scimmia Cynomolgus): caratteristiche chiave e contributi alla ricerca biomedica https://it.prisysbiotech.com/uploads/39406/news/n20240801174043f9c14.jpg https://it.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79528870.html Rivoluzionare il trattamento delle malattie metaboliche: progressi e sfide nello sviluppo di farmaci peptidici https://it.prisysbiotech.com/uploads/39406/news/n2024080117395084c9b.jpg https://it.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79528849.html Come valutare la sicurezza dei prodotti per la pelle prima delle sperimentazioni cliniche? https://it.prisysbiotech.com/uploads/39406/news/n20240801173853b9e8e.jpg https://it.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79528877.html Il ruolo significativo delle scimmie sperimentali nello sviluppo di farmaci innovativi: uno sguardo dall'interno al business https://it.prisysbiotech.com/uploads/39406/news/n20240801173640dbcdb.jpg https://it.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79528889.html La tossicità epatica come preoccupazione chiave per i farmaci a base di siRNA: un'analisi completa Specificità del bersaglio: l'arma a doppio taglio dei farmaci a base di siRNA https://it.prisysbiotech.com/uploads/39406/news/n20240801173252513ea.jpg https://it.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79528843.html Avanzamento delle terapie SiRNA: superare le sfide nello sviluppo dei farmaci https://it.prisysbiotech.com/uploads/39406/news/n2024080117311060b15.jpg https://it.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79528852.html Prospettive applicative dei farmaci genici basati sulle nanoparticelle lipidiche https://it.prisysbiotech.com/uploads/39406/news/n20240801172808b0a45.jpg https://it.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79528858.html Punti chiave nella progettazione di strategie per studi non clinici su animali giovani https://it.prisysbiotech.com/uploads/39406/news/n20240801172702f375a.jpg https://it.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79528883.html Approfondimenti sui tratti sensoriali e comportamentali dei primati non umani (NHP) https://it.prisysbiotech.com/uploads/39406/news/n2024080117261321519.jpg https://it.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79528890.html Domande e risposte sulla valutazione dello studio non clinico https://it.prisysbiotech.com/uploads/39406/news/n20240801172429e1895.jpg https://it.prisysbiotech.com/news/significance-principles-and-requirements-of-79528888.html Significato, principi e requisiti della ricerca farmacologica sulla sicurezza https://it.prisysbiotech.com/uploads/39406/news/n2024080117231644f61.jpg https://it.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79528861.html Come valutare l'efficacia farmacologica preclinica? https://it.prisysbiotech.com/uploads/39406/news/n20240801172217a2b22.jpg https://it.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79528842.html Riflessioni sugli studi di farmacologia non clinica e sulla valutazione dei farmaci terapeutici per la steatoepatite non alcolica (NASH) https://it.prisysbiotech.com/uploads/39406/news/n202408011720005c93e.jpg https://it.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79528853.html Avanzamento della ricerca sul sistema nervoso centrale e sulla CGT: Prisys Biotechnologies apre la strada https://it.prisysbiotech.com/uploads/39406/news/n202408011718404c246.jpg https://it.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79528857.html Linee guida per la raccolta del liquido cerebrospinale di primati non umani https://it.prisysbiotech.com/uploads/39406/news/n20240801171318f7961.jpg https://it.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79528848.html Considerazioni per l'interpretazione dei dati di patologia clinica nei primati non umani (NHP) e nei canini https://it.prisysbiotech.com/uploads/39406/news/n2024080117122736428.jpg https://it.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79528840.html ​​​​​​​Integrazione della valutazione della sicurezza del sistema nervoso centrale negli studi tossicologici generali https://it.prisysbiotech.com/uploads/39406/news/n2024080117110558056.jpg https://it.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79528866.html Come condurre la valutazione preclinica farmacologica/tossicologica degli ADC? https://it.prisysbiotech.com/uploads/39406/news/n20240801170828e5c98.jpg https://it.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79528854.html ADME Insights per farmaci oligonucleotidici (1) - Assorbimento, distribuzione https://it.prisysbiotech.com/uploads/39406/news/n202408011705192b402.jpg https://it.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79528879.html ADME Insights per farmaci oligonucleotidici (2) - Metabolismo ed escrezione https://it.prisysbiotech.com/uploads/39406/news/n20240801164818e22a4.jpg https://it.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79528831.html Studi preclinici sugli animali (1) - Specie animali https://it.prisysbiotech.com/uploads/39406/news/n202408011646162c426.jpg https://it.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79528839.html Sfide e strategie di interpretazione dei dati di patologia clinica negli studi preclinici su cani e primati non umani https://it.prisysbiotech.com/uploads/39406/news/n20240801164503e9bd9.jpg https://it.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79528887.html Studi preclinici sugli animali (2) - Vie e volumi di somministrazione https://it.prisysbiotech.com/uploads/39406/news/n20240801163712d0df1.jpg https://it.prisysbiotech.com/news/mrna-based-therapies-present-79528882.html Terapie basate su MRNA: Presente https://it.prisysbiotech.com/uploads/39406/news/n2024080118104113739.jpg https://it.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79528881.html Terapie basate sull'MRNA: futuro e sfide https://it.prisysbiotech.com/uploads/39406/news/n2024080118092133eb2.jpg https://it.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79528865.html Breve introduzione sull'analisi biologica della terapia genica https://it.prisysbiotech.com/uploads/39406/news/n202408011807079dc4e.jpg https://it.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410785.html Scimmia Cynomolgus nella ricerca sui farmaci oftalmici https://it.prisysbiotech.com/uploads/39406/news/n2024072509180742b12.png https://it.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410786.html Studi traslazionali e cross-reattivi con i modelli NHP di immunologia e infiammazione di Prisys https://it.prisysbiotech.com/uploads/39406/news/n2024072212200879ff1.png https://it.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79191366.html NHP non naïve negli studi preclinici: una soluzione economicamente vantaggiosa di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n2024071618013071b40.png https://it.prisysbiotech.com/news/nhp-asthma-model-79191365.html Modello di asma NHP: potenziamento degli studi preclinici sull'efficacia dei farmaci con Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n202407051359254acc6.png https://it.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79191369.html Avanzamento della ricerca sull'immunologia e l'infiammazione con modelli di macachi cynomolgus - Prisys Biotechnologies https://it.prisysbiotech.com/uploads/39406/news/n20240703110911ef80e.png https://it.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79191363.html Consegna diretta di farmaci oligonucleotidici al sistema nervoso centrale e cambiamenti istopatologici comuni https://it.prisysbiotech.com/uploads/39406/news/n202406131052303d31d.png https://it.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79191364.html Modello di ictus intracerebrovascolare (ICH) di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n20240607164926587f9.png https://it.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75161208.html Ricerca farmacodinamica non clinica: un aspetto essenziale nello sviluppo di farmaci SiRNA https://it.prisysbiotech.com/uploads/39406/news/n202402211320123fe5b.jpg https://it.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77700577.html Il sistema di localizzazione e rilascio di precisione del sistema nervoso centrale per animali di grandi dimensioni guidato dalla risonanza magnetica si stabilisce in Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://it.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77052058.html Soluzioni innovative per il progresso della terapia respiratoria https://it.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://it.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74783204.html Prisys: progresso della sperimentazione animale attraverso gli studi sui macachi Cynomolgus https://it.prisysbiotech.com/uploads/39406/news/n202402271423376ec81.png https://it.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76173947.html Prisys ottiene il pieno accreditamento da AAALAC International: una pietra miliare nel garantire standard elevati di cura degli animali da laboratorio. https://img01.v15cdn.com/gallery/4x3/265.webp https://it.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654702.html Miglioramento delle terapie sugli acidi nucleici grazie ai modelli di primati non umani di Prisys Biotech https://it.prisysbiotech.com/uploads/39406/news/n202401261332041ba3c.jpg https://it.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74129346.html Rivoluzionare la somministrazione di farmaci al sistema nervoso centrale: Prisys e la promessa dell'iniezione intratecale https://it.prisysbiotech.com/uploads/39406/news/n20240111101138bd6a1.jpg https://it.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75161202.html Newsletter Prisys Biotech 2024 Q1: il tuo affidabile specialista nello studio sui primati non umani https://it.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://it.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73528812.html In che modo la biopsia epatica guidata dagli ultrasuoni migliora la ricerca basata sui macachi https://it.prisysbiotech.com/uploads/202339406/n202312211047254501881.jpg https://it.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73528811.html Linee guida per l'uso permanente dei primati non umani nella ricerca biomedica: una prospettiva biotecnologica di Prisys https://it.prisysbiotech.com/uploads/39406/news/n202402271428388db72.png https://it.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001234.html Primati non umani: una breve introduzione alle loro caratteristiche biologiche https://it.prisysbiotech.com/uploads/39406/news/n202402271431193773d.png https://it.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72675081.html Recensione della mostra|Prisys Biotech brilla al meeting annuale della American Society For Neuroscience (SfN 2023) https://it.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://it.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321407.html Incontra Prisys Biotech al convegno annuale della Society For Neuroscience (SfN 2023) https://it.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://it.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321409.html Giornata mondiale contro l'ictus|Focus sui modelli animali e sulla farmacologia dell'ictus ischemico https://it.prisysbiotech.com/uploads/202339406/n202310292017544133660.jpg https://it.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321410.html Prisys Biotech ti invita a partecipare al meeting annuale SAPA-China nel 2023 https://it.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://it.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321412.html Giornata mondiale dell'Alzheimer|Le sfide e le soluzioni per lo sviluppo di farmaci per l'AD https://it.prisysbiotech.com/uploads/202339406/n202309211504565472671.jpg https://it.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321408.html Il modello animale di macaco Cynomolgus di Prisys Biotech aiuta lo sviluppo di nuovi farmaci anticoagulanti https://it.prisysbiotech.com/uploads/202339406/n202309182207050266461.png https://it.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70946501.html Prisys: Fornire Alta qualità Animale Esperimento Servizio Per Il Romanzo Anticoagulazione Fattore XI Anticorpo BJTJ-1837 https://it.prisysbiotech.com/uploads/202339406/n202308311332528401166.jpg https://it.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70946390.html Metodo per stabilire un modello di ipertrigliceridemia della scimmia Cynomolgus e la sua applicazione https://it.prisysbiotech.com/uploads/202339406/n202308212156285814136.jpg https://it.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70946393.html Farmacologia: parametri principali e significato della farmacocinetica (PK) https://it.prisysbiotech.com/uploads/202339406/n202308091145033318894.jpg https://it.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70946386.html Valutazione farmacologica preclinica dei farmaci contro i virus oncolitici https://it.prisysbiotech.com/uploads/202339406/n202308071041585027430.jpg https://it.prisysbiotech.com/news/0-70946387.html Come i farmaci a base di piccoli acidi nucleici possono trasformare il trattamento delle malattie del sistema nervoso centrale: approfondimenti da Prisys Biotechnology, fornitore leader di CRO di modelli di malattie NHP https://it.prisysbiotech.com/uploads/202339406/n202308041018581481730.jpg https://it.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70946405.html Farmacocinetica, strategie di ricerca e casi di studio di farmaci peptidici https://it.prisysbiotech.com/uploads/202339406/n202308031715493686411.jpg https://it.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69654101.html Punti chiave della ricerca sulla PK del farmaco ADC https://it.prisysbiotech.com/uploads/202339406/n202307302137108622628.jpg https://it.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69655920.html Prisys Biotechnology: un leader nella piattaforma di ricerca sulla modellizzazione delle malattie del sistema nervoso centrale NHP https://it.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://it.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309277.html Come perdere peso e controllare il diabete con i prodotti GLP-1 https://it.prisysbiotech.com/uploads/202339406/n202307162139405018976.jpg https://it.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309393.html In che modo China Monkey aiuta a condurre una ricerca preclinica efficiente? https://it.prisysbiotech.com/uploads/39406/news/n20240227143532bd79a.png https://it.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309372.html Qual è l'efficienza dell'RNAi? https://it.prisysbiotech.com/uploads/202339406/n202307092210201669077.jpg https://it.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309408.html Prisys Biotech Piattaforma di servizi pubblici per esperimenti su animali di grandi dimensioni: soluzione a basso costo e ad alta efficienza per esperimenti su animali di grandi dimensioni https://it.prisysbiotech.com/uploads/39406/news/n2024022714394317bcf.png https://it.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69044911.html In che modo la terapia genica AAV può salvare la vista: le ultime scoperte dagli studi sui primati non umani https://it.prisysbiotech.com/uploads/202339406/n202307022231508642715.jpg https://it.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69074011.html Prisys Biotech presenta una piattaforma di modelli di primati non umani all'incontro annuale della Società giapponese di tossicologia https://it.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://it.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69010443.html Il futuro promettente della terapia genica AAV nei primati non umani https://it.prisysbiotech.com/uploads/202339406/n202306232107539553735.jpg https://it.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69098190.html Cosa sono le nanoparticelle lipidiche per la terapia genica? https://it.prisysbiotech.com/uploads/202339406/n202306182144004132789.jpg https://it.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-68998026.html Prisys Biotech ti invita a partecipare al 50° meeting annuale della Japanese Society of Toxicology (JSOT) https://it.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://it.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-68997316.html Test di immunotossicità, valutazione della sicurezza dei farmaci-PRISYS BIOTECH https://it.prisysbiotech.com/uploads/202339406/n202306102132091628389.jpg https://it.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68314212.html Un modello animale ottimale di ictus ischemico stabilito dalla sottrazione digitale di trombi autologhi guidati dall'angiografia nelle scimmie Cynomolgus https://it.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://it.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68103784.html Perché dovresti preoccuparti dei primati non umani nella ricerca e nello sviluppo del sistema di somministrazione di farmaci con acido nucleico https://it.prisysbiotech.com/uploads/202339406/n202305282122338248983.jpg https://it.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68103782.html Incontra Prisys Biotech al 70° JALAS 2023! https://it.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://it.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68103792.html La terapia genica brilla con nuove approvazioni per le malattie rare https://it.prisysbiotech.com/uploads/202339406/n202305162133347179081.jpg https://it.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68103788.html Rivoluzionando la scoperta di farmaci: come i primati non umani stanno ottimizzando lo screening del SiRNA per risultati più rapidi ed efficienti https://it.prisysbiotech.com/uploads/39406/news/n20240227144111404cb.png https://it.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67263944.html Massimizzare l'efficienza farmacologica di SiRNA con la ricerca sui primati non umani https://it.prisysbiotech.com/uploads/202339406/n202305022215194112233.jpg https://it.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67263945.html Come i primati non umani possono rivoluzionare la ricerca sui siRNA: una guida completa https://it.prisysbiotech.com/uploads/202339406/n202304272138362221911.jpg https://it.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67263938.html Celebrando la Giornata mondiale per gli animali da laboratorio: perché Prisys si impegna a promuovere la salute dei primati non umani https://it.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://it.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67263941.html Massimizzare l'efficienza della ricerca CRISPR/Cas9 con modelli di primati non umani https://it.prisysbiotech.com/uploads/202339406/n202304221149520486556.jpg https://it.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67263940.html Scatenare il potenziale terapeutico: perché investire in farmaci a base di acido nucleico è il futuro della medicina https://it.prisysbiotech.com/uploads/202339406/n202304200850383332884.jpg https://it.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67263943.html Sbloccare il potenziale dei primati non umani nel migliorare la scoperta di bersagli di farmaci per la terapia genica https://it.prisysbiotech.com/uploads/202339406/n202304142148160397375.jpg https://it.prisysbiotech.com/news/world-parkinsons-disease-day-67263939.html Uniti per il Parkinson: unire le mani per aumentare la consapevolezza in occasione della Giornata mondiale del morbo di Parkinson https://it.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://it.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67263942.html Come utilizzare efficacemente i primati non umani nella valutazione della sicurezza della terapia genica https://it.prisysbiotech.com/uploads/202339406/n202304102117431547381.jpg https://it.prisysbiotech.com/news/gene-therapy-toxicology-66269247.html Ricerca sulla tossicologia della terapia genica con il primate nonhuam https://it.prisysbiotech.com/uploads/202339406/n202304052050241172289.jpg https://it.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66086010.html Una guida completa per condurre lo studio DMPK per la terapia genica https://it.prisysbiotech.com/uploads/202339406/n202303292053463875854.jpg https://it.prisysbiotech.com/news/gene-therapy-nhp-model-66086005.html Rivoluzionare la ricerca medica: progressi della terapia genica nei modelli di malattie dei primati non umani! https://it.prisysbiotech.com/uploads/202339406/n202303282057377312705.jpg https://it.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66086008.html Le 10 domande più frequenti relative alla terapia genica https://it.prisysbiotech.com/uploads/202339406/n202303241229248740600.jpg https://it.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66086009.html Prisys Biotech: farmacologia dei primati non umani per la terapia genica https://it.prisysbiotech.com/uploads/202339406/n202303241128310077112.jpg https://it.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66086006.html Sostenere la salute delle donne: uno sguardo all'endometriosi https://it.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://it.prisysbiotech.com/news/prisys-sot2023-66086007.html PRISYS e Taichu Group stanno collaborando per la fiera SOT nel 2023 https://it.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://it.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66086004.html Abbiamo bisogno di ulteriori studi per la valutazione del dolore? - NHP https://it.prisysbiotech.com/uploads/202339406/n202303081329477852711.jpg https://it.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66086002.html Unisciti a noi per celebrare la Giornata mondiale della fauna selvatica https://it.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://it.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66086593.html Lancio del Prisys Shanghai NHP R&D Center, che segna una pietra miliare nella ricerca e nello sviluppo farmaceutico in Cina https://it.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://it.prisysbiotech.com/news/meetprisys-sot2023-66086003.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://it.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg